Answers are grounded in this paper and cite their sources.
Therapeutic resistance in cancer is a critical problem that often requires simultaneously targeting multiple genes or pathways. Given the high costs of drug development, the exploration of existing approved drugs is gaining popularity in cancer research. Within this context, druggable gene networks, defined as sets of functionally related and frequently altered genes that are targeted by approved drugs, represent a promising framework for identifying potential therapeutic options. This search for druggable gene networks can be formulated as a multi-objective optimization problem where gene druggability, patient mutation coverage, and network correlation need to be simultaneously maximized. To address this challenge, we propose an Objective Space Partitioning Algorithm for Druggable GEne NEtwork Detection (OSPA-DGENED), which employs a set of reference points to balance convergence and diversity during the evolutionary process. Furthermore, our approach incorporates problem-specific operators that leverage biological information to produce high-quality solutions. We evaluated OSPA-DGENED’s performance against six state-of-the-art methods across 27 biological scenarios derived from real cancer data. OSPA-DGENED achieved statistically significant improvements over all compared methods in every experimental scenario. These results, along with the biological analysis of the solutions, highlight the effectiveness of the proposed approach in detecting high-quality and biologically relevant druggable gene networks.
No takes yet. Share an insight, caveat, or question.
Rodríguez-Bejarano et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: